Back to stocks
ENTA

ENTA

Enanta Pharmaceuticals, Inc.• Healthcare

Q3 2026 filings are still coming in. 13F filers have 45 days after the quarter ends to report, through November 14, 2026. These totals cover only the funds that have filed so far and will keep rising.
Institutional holders
22
Partial Q3 2026
Total 13F value
$485K
Filed positions so far
New positions
2
This quarter
Sold positions
3
This quarter

Top holders

Institutions with disclosed positions in this stock

FundValueShares% PortfolioChange

Wealth Enhancement Advisory Services, Llc

$143K11.8K0.00%-11.1%

Northeast Investment Management

$132K10.0K0.00%New Position

China Universal Asset Management Co., Ltd.

$67K5.3K0.00%+14.8%

Pinnacle Wealth Planning Services, Inc.

$33K2.5K0.00%Unchanged

Gamma Investing Llc

$21K1.6K0.00%+19.3%

Mirae Asset Global Investments Co., Ltd.

$20K1.5K0.00%+14.5%

Versant Capital Management, Inc

$19K1.4K0.00%Unchanged

Sterling Capital Management Llc

$10K7400.00%+116.4%

Gf Fund Management Co. Ltd.

$9K6690.00%+8.4%

True Wealth Design, Llc

$8K6080.00%-5.7%

Ifp Advisors, Inc

$5K4000.00%-0.5%

Essential Partners Llc

$5K3800.00%Unchanged

Nisa Investment Advisors, Llc

$4K3400.00%Unchanged

Farther Finance Advisors, Llc

$2K1780.00%+2.3%

Parkside Financial Bank & Trust

$2K1510.00%+112.7%

Signaturefd, Llc

$2K1330.00%New Position

Fortitude Family Office, Llc

$1K1110.00%Unchanged

Torren Management, Llc

$778590.00%Unchanged

Caitong International Asset Management Co., Ltd

$395300.00%+275.0%

Tfc Financial Management, Inc.

$1410.00%Unchanged

Hughes Financial Services, Llc

$1110.00%Unchanged

Covestor Ltd

$0140.00%-41.7%

Explore